Caliper Life Sciences Inc. (NSDQ:CALP) formed a scientific advisory board of DNA sequencing experts and launched its first gene sequencing instrument, the LabChip XT.
The Hopkinton, Mass.-based lab instruments maker said it will work with the members of its new board to identify opportunities to improve sequencing workflows using its microfluidics technology.
One such opportunity is automated nucleic acid fractionation, which the LabChip XT is designed to address. The device eliminates a sequencing bottleneck by removing the need for gel isolation and purification, according to a press release. The device uses a microfluidic chip to simultaneously process multiple samples.
The members of Caliper’s new Sequencing Scientific Advisory Board are:
- Karen Beeson, J. Craig Venter Institute
- Patrick Cahill, The Broad Institute of MIT and Harvard
- Jan Fang Cheng, U.S. Department of Energy – Joint Genome Institute
- Christopher Detter, U.S. Department of Energy – Joint Genome Institute
- John Gill, J. Craig Venter Institute
- Vincent Magrini, Washington University Genome Sequencing Center
- Michael Quail, Wellcome Trust Sanger Institute